Here are six points:
1. The Proteus Ingestible Sensor received FDA approval in July.
2. The sensor fits inside a sensor-enabled pill and is edible.
3. A patch on a patient’s body knows when the pill reaches the stomach, and alerts both the patient and physician through a Discover app.
4. Pill location, heart rate, steps, blood pressure and rest information is all sent via Bluetooth to the app.
5. Physicians can use this information to monitor if patients are taking medication at the proper time and evaluate their progress.
6. Proteus and Otsuka Pharmaceutical designed a pill called ABILFY that encompasses the Proteus Ingestible Sensor; it is waiting for FDA review.
More on quality & infection control:
New vaccine taking on glioblastoma brain tumors: 5 points
5-step handwashing helps reduce sickness-related absenteeism for students — 5 things to know
Research paves way for MRSA vaccine — 5 findings
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
